
Pharmaceuticals • Biotechnology • Healthcare Insurance
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). The company achieved a significant milestone with the accelerated FDA approval of its first therapy for adults with NASH with moderate to advanced liver fibrosis. Madrigal is actively conducting a Phase 3 trial for the treatment of NASH with compensated cirrhosis. The company is dedicated to improving care for patients with NASH/MASH through its ambitious research programs and therapeutic developments.
51 - 200 employees
💊 Pharmaceuticals
🧬 Biotechnology
⚕️ Healthcare Insurance
💰 $259M Post-IPO Equity on 2022-12
November 21

Pharmaceuticals • Biotechnology • Healthcare Insurance
Madrigal Pharmaceuticals is a biopharmaceutical company focused on developing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). The company achieved a significant milestone with the accelerated FDA approval of its first therapy for adults with NASH with moderate to advanced liver fibrosis. Madrigal is actively conducting a Phase 3 trial for the treatment of NASH with compensated cirrhosis. The company is dedicated to improving care for patients with NASH/MASH through its ambitious research programs and therapeutic developments.
51 - 200 employees
💊 Pharmaceuticals
🧬 Biotechnology
⚕️ Healthcare Insurance
💰 $259M Post-IPO Equity on 2022-12
• support the strategic goals of the GHEOR, Global Medical Affairs (GMA) and broader business driving patient access with optimal pricing and reimbursement for Madrigal Pharmaceutical’s medicines • develop and execute RWE projects and strategies against global integrated evidence plans • analyze complex real-world data (RWD) • design, build, and maintain internal data warehouses • maintain reproducible analytical pipelines and RWE platforms using R programming • execute both rapid analyses and full protocol-driven observational studies • adhere to FDA and EMA regulatory guidance to produce high-quality evidence • present at scientific conferences and publish in key journals
• Graduate degree in biostatistics, public health, epidemiology, or a similar field • 10-12+ years of relevant experience • In-depth experience with R programming, version control and collaborative development tools (e.g., GitHub) • Expertise in applying advanced statistical analytic methodologies to RWD • Familiarity with common commercially available RWD data assets encompassing administrative claims and EHR databases • Experience in delivering ad-hoc and full protocol-driven observational studies • Experience with liver / metabolic diseases in the RWD space would be preferred • A strong track record of publications • Strong communication skills • High proficiency with project management systems, Medical Affairs dashboards, CRM platforms, and enterprise collaboration tools (e.g., Veeva, Microsoft Office Suite, SharePoint, Teams, Zoom)
• flexible paid time off • medical insurance • dental insurance • vision insurance • life/disability insurance • 401(k) offerings (traditional, Roth, and employer match) • additional voluntary benefits like supplemental life insurance and legal services • mental health benefits through Employee Assistance Program
Apply NowNovember 21
Associate Director in analytics consulting for Tiger Analytics, applying advanced Data Science and MLOps to solve business problems. Leading analytics projects with a focus on client relationship management.
November 21
Associate Director managing contracting for Organon’s health care products in the US, optimizing net sales and collaborating with cross-functional teams.
🇺🇸 United States – Remote
💵 $125.4k - $213.1k / year
💰 $3M Seed Round on 2024-02
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
November 21
Strategic leadership role managing the rebate invoicing and audit operations at Synergie Medication Collective. Driving client value and collaborating across teams in healthcare environments.
November 21
Senior Director leading U.S. congressional affairs and lobbying strategy at Nokia. Driving advocacy campaigns and stakeholder engagement for technology policy.
🇺🇸 United States – Remote
💵 $147.6k - $274.1k / year
💰 Post-IPO Debt on 2018-12
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
November 21
AIM 28 Business Modernization Senior Director at McKesson driving AI-enabled transformation within the healthcare sector. Leading initiatives to integrate AI capabilities and ensure successful adoption across business functions.